Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: 1  reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven't been diagnosed but are at higher-than-average risk for disease.
Types of paper ICT Express publishes original research papers in English in the fields of ICT convergence, platform technologies, communication networks, and device technologies. ICT Express accepts short-length (up to 4 pages in double columns and additional 2 pages will be allowed with over page charge (100USD/1page)) high-quality, original articles in Latex or Word format. Sample manuscript can be downloaded here.
Revisions â 5 Days. Once formatting is complete, you will be able to view your eBook and request formatting changes. Once you submit your revisions via your Publish Green account, your formatter has 5 business days to make the changes and get the new version back to you. This is true of each round of revisions. Once one round of revisions is completed, you may enter another round of revisions or approve the final formatting.